Hangzhou Tigermed: revenue grows, but nine-month results swing to a loss
Hangzhou Tigermed's nine-month revenue rose 15.23%, but attributable net loss reached RMB 272.0m on heavy fair-value losses, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Hangzhou Tigermed Consulting reported revenue growth of 15.23% for the first nine months. It also posted an attributable loss of RMB 272.0m. According to TradingView, the main drivers were large fair-value losses and weaker investment income.
Adjusted attributable income, however, climbed 38.08%, and third-quarter revenue increased 17.38%.
why it matters
The picture is mixed: operating growth and adjusted profit look strong, but fair-value losses turned the reported result into a loss. Investors often watch closely for gaps between reported and adjusted earnings. The story concerns a single company, so its impact on the broader market is limited.
market impact
Hangzhou Tigermed shares: reported fair-value loss outweighs revenue and adjusted profit growth
tags
instruments
sources
- HANGZHOU TIGERMED CONSULTING: Revenue grew, but large fair-value losses drove a 9M attributable net loss — TradingView, 29 October 2026 at 08:53 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗